A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Clinical trial NCT07223138 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07223138
- Sponsor
- MoonLake Immunotherapeutics AG
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-13
- Primary completion
- 2028-02-04
- Enrollment
- 1560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.